New trial aims to cut side effects of radiation for recurrent prostate cancer

NCT ID NCT04190446

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This phase II trial tests two types of radiation therapy (proton beam or IMRT) given in fewer, larger doses for men whose prostate cancer has returned or spread to a few spots after initial treatment. The main goal is to see if this shorter course causes fewer serious side effects in the gut and urinary tract. About 84 men will take part, and the study is actively recruiting.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
radiation therapy (proton beam or intensity-modulated radiation therapy)
What this could lead to
If successful, this could offer a shorter, safer radiation option for men with recurrent prostate cancer that has spread to a few sites.
What could go wrong
This is a small, early-phase trial (84 people) focused on side effects, not on curing the cancer. It may not lead to better outcomes or be widely applicable.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METASTATIC PROSTATE ADENOCARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Mayo Clinic in Rochester

    Rochester, Minnesota, 55905, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.